Is Chromium an Important Element in HIV-Positive Patients with Metabolic Abnormalities? An Hypothesis Generating Pilot Study

Journal of the American College of Nutrition

Volumn 25, Issue 1, 2006, Pages 56-63

  Aghdassi, Elaheh ^a   Salit, Irving E ^a   Fung, Lillia ^a   Sreetharan, Lavaniya ^a   Walmsley, Sharon ^a   Allard, Johane P ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Body composition; Chromium; Glucose; HIV; Lipid; Lipodystrophy

Indexed keywords

ANTIRETROVIRUS AGENT; CHROMIUM; INSULIN; LIPID;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL FEATURE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIPID METABOLISM; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; URINARY EXCRETION; BLOOD; CASE CONTROL STUDY; CHEMISTRY; CROSS-SECTIONAL STUDY; DIET; GLUCOSE BLOOD LEVEL; HIV ASSOCIATED LIPODYSTROPHY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; NAIL; PILOT STUDY; URINE;

ADULT; ANTI-RETROVIRAL AGENTS; BLOOD GLUCOSE; BODY COMPOSITION; CASE-CONTROL STUDIES; CHROMIUM; CROSS-SECTIONAL STUDIES; DIET; FEMALE; HIV SEROPOSITIVITY; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INSULIN; LIPIDS; MALE; NAILS; PILOT PROJECTS;

EID: 33746234887     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2006.10719515     Document Type: Article

References (67)

1. Roberts AD, Muesing A, Parenti DM, Hsia J, Wasserman AG, Simon GL: Alterations in serum levels of lipids and lipoproteins with indinavir therapy for human immunodeficiency virus-infected patients. Clin Infect Dis 29: 441-443, 1999.
2. Carr A, Samaras K, Chisolm DJ, Cooper DA: Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidemia and insulin resistance. Lancet 351: 1881-1883, 1998.
3. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA: Diagnosis, prediction, and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: a cohort study. Lancet 353: 2093-2099, 1999.
4. Carr A, Samaras K, Burton S, Law A, Freund J, Chrisholm DJ, Cooper DA: A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: F51-58, 1998.
5. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M: "Buffalo hump" in men with HIV-1 infection. Lancet 351: 867-870, 1998.
6. Miller KD, Jones E, Yanovski JA, Shankar R, Feuerstein I, Falloon J: Visceral abdominal fat accumulation associated with use of indinavir. Lancet 351: 871-875, 1998.
7. Anderson RA, Polansky MM, Bryden NA, Bhathena SJ, Canary J: Effect of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism 36: 351-355, 1987.
8. Saad MJA: Molecular mechanisms of insulin resistance. Brazilian J Med Biol Res 27: 941-957, 1994.
9. Kahn CR: Current concepts of the molecular mechanism of insulin action. Ann Rev Med 36: 429-451, 1985.
10. Roth RA, Lui F, Chin JE: Biochemical mechanisms of insulin resistance. Horm Res 41: 51-55, 1994.
11. Davis CM, Vincent JB: Chromium oligopeptide activates insulin receptor kinase activity. Biochemistry 36: 4382-4385, 1997.
12. Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingrebristen TS, Anderson RA, Graves DJ: Regulation of phosphotyrosine phosphatase (PTP-1) and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signaling. Horm Res 50: 177-182, 1999.
13. Davis CM, Sumall KH, Vincent JB: A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry 35: 12963-12969, 1996.
14. Anderson RA, Bryden NA, Polansky M: Chromium content of selected breakfast cereals. J Food Comp Anal 1: 303-308, 1988.
15. Anderson RA, Bryden NA, Polansky MM: Dietary chromium intake: Freely chosen diets, institution diets, and individual foods. Biol Trace Elem Res 32: 117-121, 1992.
16. O'Heany JM: Summary of health effects of chromium. Health studies service, special studies and service branch, Ontario Ministry of Labour, 1986.
17. Underwood EJ: "Trace Elements in Human and Animal Nutrition," 4th ed. New York: Academic Press, pp 258-270, 1977.
18. Donaldson RM, Jr. and Barreras RF: Intestinal absorption of trace quantities of chromium. J. Lab Clin Med 68: 484-493, 1966.
19. Anderson RA, Kozlovsky AS: Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr 41: 1177-1183, 1985.
20. Sipowicz MA, Anderson LM, Utermahlen WE, Issaq HJ, Kasprzak KS: Uptake and tissue distribution of chromium III in mice after a single intraperitoneal or subcutaneous administration. Toxicol Lett 9-14, 1997.
21. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Patterson KJ, Vellon C, Glinsmann W: Urinary chromium excretion of human subjects: effects of chromium supplementation and glucose loading. Am J Clin Nutr 36: 1184-1193, 1982.
22. Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C, Gray TA: Chromium homeostasis in patients with type II (NIDDM) diabetes. J Trace Elements Med Biol 13: 57-61, 1999.
23. Morris BW, Kouta S, Robinsont R, MacNeil S, Hellert S: Chromium supplementation improves insulin resistance in patients with type 2 diabetes. Diabetic Med 17: 684-686, 2000.
24. Morris BW, Peacey SR, MacNeil S, et al: Enhancement in insulin sensitivity in healthy volunteers following supplementation with chromium picolinate. J Med Biochem 1: 65-72, 1998.
25. Evans GW: The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res 11: 163-180, 1989.
26. Anderson RA, Cheng N, Bryden NA, Polansky M, Cheng N, Chi J, Feng J: Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46: 1786-1791, 1997.
27. Baum MK, Shor-Posner G, Lu Y, Rosner B, Sauberlich HE, Fletcher MA, Szapocznik J, Eisdorfer C, Buring JE, Hennekens CH: Micronutrients and HIV-1 disease progression. AIDS 9: 1051-1056, 1995.
28. Coodley G, Girard DE: Vitamins and minerals in HIV infection. J Gen Intern Med 6: 472-479, 1991.
29. Moseson M, Zeleniuch-Jacquette A, Belisto DV, Share RE, Marmor M, Pasternack B: The potential role of nutritional factors in the indication of immunologic abnormalities in HIV positive homosexual men. J Acquir Immune Defic Syndr 2: 235-247, 1989.
30. Coodley GO, Coodley MK, Nelson HD, Loveless MO: Micronutrient concentrations in the HIV wasting syndrome. AIDS 7: 1595-1600, 1993.
31. Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S: Oxidative stress and plasma antioxidant micronutrients in human with HIV infection. Am J Clin Nutr 67: 143-147, 1998.
32. Brook CGD: Determination of body composition of children from skin fold measurements. Arch Dis Child 46: 182-184, 1971.
33. Durnin JVGA, Rahaman MM: The assessment of the amount of fat in the human body from measurements of skin fold thicknesses. Br J Nutr 21: 681-683, 1967.
34. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41: 810-817, 1985.
35. Brady LM, Gower BA, Lovegrove SS, Williams CM, Lovegrove JA: Revised QUICKI provides a strong surrogate estimate of insulin sensitivity when compared with the minimal model. Int J Obes 28: 222-227, 2004.
36. Expert committee on the diagnosis and classification of diabetes mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 21: S5-19, 1998.
37. Hokanson KE, Austin MA: Plasma triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3: 213-219, 1996.
38. National cholesterol education program: Second report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel II). Circulation 89: 1333-1445, 1993.
39. Burchfiel CM, Laws A, Benfante R, Goldberg RJ, Hwang LJ, Chiu D, Rodriguez BL, Curb JD, Sharp DS: Combined effect of HDL cholesterol, triglyceride and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation 92: 1430-36, 1995.
40. Anderson RA, Bryden NA: Concentration, insulin potentiation, and absorption in beer. J Agric Food Chem 31: 309-311, 1983.
41. Bratakos MS, Zaws ES, Brakatos SM: Chromium content of selected Greek foods. Sci Total Environ 290: 47-59, 2002.
42. Miller-Inli NS: Graphite furnace atomic absorption spectrometry for the determination of the chromium content of selected U.S. foods. J Food Comp Analysis 9: 290-300, 1996.
43. Jorhem L, Sunastrom B: Levels of lead, cadmium, zinc, copper, nickel, chromium, manganese, and cobalt in food on the Swedish market, 1983-1990. J Food Comp Analysis 6: 223-241, 1993.
44. Lendinez E, Lorenzo ML, Cobrera C, Lopez MC: Chromium in basic foods of Spanish diet: seafood, cereals, vegetables, olive oils and dairy products. Sci Total Environ 279: 183-189, 2001.
45. Hill AD, Patterson KY, Veillon C, Morris ER: Digestion of biological materials for mineral analysis using a combination of wet and dry ashing. Anal Chem 58: 2340-2342, 1986.
46. Anderson RA, Bryden NA, Evock-Clover CM, Steele NC: Beneficial effects of chromium on glucose and lipid variables in control and somatotropin-treated pigs are associated with increased tissue chromium and altered tissue copper, iron and zinc. J Anim Sci 75: 657-661, 1997.
47. Anderson RA, Bryden NA, Polansky MM, Reiser S: Urinary chromium excretion and insulinogenic properties of carbohydrates. Am J Clin Nutr 51: 864-868, 1990.
48. Garland M, Morris JS, Colditz GA, Stampfer MJ, Spate VL, Baskett CK, Rosner B, Speizer FE, Willett WC, Hunter DJ: Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol 144: 653-660, 1996.
49. Nolan D, John M, Malla S: Antiretroviral therapy and the lipodystrophy Syndrome, part 2: concepts in aetiopathogenesis. Antivir Ther 6: 145-160, 2001.
50. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A: Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30: 531, 1977.
51. Anderson R: Recent advances in the clinical and biochemical effects of chromium deficiency. In Prasad AS (ed): "Essential and Toxic Trace Elements in Human Health and Disease." New York: Wiley Liss, pp 221-234, 1993.
52. Anderson RA: Chromium, glucose tolerance, diabetes and lipid metabolism. J Adv Med 8: 37-49, 1995.
53. Mertz W: Chromium in human nutrition: A review. J Nutr 123: 626-633, 1993.
54. Czech MP, Corvera S: Signaling mechanisms that regulate glucose transport. J Biol Chem 274: 1865-1868, 1999.
55. Birnbaum MJ: Identification of a novel gene encoding an insulinresponsive glucose transporter protein. Cell 57: 305-315, 1989.
56. Murata H, Hruz PW, Mueckler M: The mechanism of insulin resistance caused by HIV proteinase inhibitor therapy. J Biol Chem 275: 20251-20254, 2000.
57. Anderson RA: Chromium metabolism and its role in disease processes in man. Clin Physiol Biochem 4: 31, 1986.
58. Cline GW, Petersen KF, Krssak M, Shen J, Hundal RS, Trajanoski Z, Inzucchi S, Dresner A, Rothman DL, Shulman GI: Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341: 240-246, 1999.
59. Earle CE, Archer AG, Bailllie JE: Circulating and excreted levels of chromium after an oral glucose challenge: influence of body mass index, hypoglycemic drugs, and presence and absence of diabetes mellitus. Am J Clin Nutr 49: 685-689, 1989.
60. Davies S, McLaren HJ, Hunnisett HA: Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients: implications for the prevention of cardiovascular diseases and type II diabetes. Metabolism 46: 469-473, 1997.
61. Modan M, Karasik A, Halkin H, Fuchs Z, Lusky A, Shitrit A, Modan B: Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin dependent) diabetes and on insulin response. Diabetologia 29: 82-89, 1986.
62. Mahdi GS, Naismith DJ: Role of chromium in barley in modulating the symptoms of diabetes. Ann Nutr Metab 35: 65-70, 1991.
63. Abraham AS, Brooks BA, Eylath U: The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin dependent diabetes. Metabolism 41: 768-771, 1992.
64. Uyanik F: The effects of dietary chromium supplementation on some blood parameters in sheep. Biol Trace Element Res 84: 93-99, 2001.
65. Hopkins LL, Ransome-Kati O, Majaj AS: Improvement of impaired carbohydrate metabolism by chromium 3 in malnourished infants. Am J Clin Nutr 21: 203-211, 1968.
66. Riales R, Albrink MJ: Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr 34: 2670-2678, 1983.
67. Anderson RA: Chromium in the prevention and control of diabetes. Diabetes Metab 26: 22-7, 2000.